213 related articles for article (PubMed ID: 25912932)
1. The economic burden of gout: A systematic review.
Rai SK; Burns LC; De Vera MA; Haji A; Giustini D; Choi HK
Semin Arthritis Rheum; 2015 Aug; 45(1):75-80. PubMed ID: 25912932
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of the Economic and Humanistic Burden of Gout.
Shields GE; Beard SM
Pharmacoeconomics; 2015 Oct; 33(10):1029-47. PubMed ID: 25969152
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.
Wu EQ; Forsythe A; Guérin A; Yu AP; Latremouille-Viau D; Tsaneva M
Am J Ther; 2012 Nov; 19(6):e157-66. PubMed ID: 21317625
[TBL] [Abstract][Full Text] [Related]
4. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
Robinson LS; Sarkies M; Brown T; O'Brien L
Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
[TBL] [Abstract][Full Text] [Related]
5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of uncontrolled gout: how controlling gout reduces cost.
Flores NM; Nuevo J; Klein AB; Baumgartner S; Morlock R
J Med Econ; 2019 Jan; 22(1):1-6. PubMed ID: 30289009
[TBL] [Abstract][Full Text] [Related]
7. The economic impact of gout: a systematic literature review.
Trieste L; Palla I; Fusco F; Tani C; Baldini C; Mosca M; Turchetti G
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S145-8. PubMed ID: 23072897
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of health care costs and utilization patterns for patients with gout.
Park H; Rascati KL; Prasla K; McBayne T
Clin Ther; 2012 Mar; 34(3):640-52. PubMed ID: 22381710
[TBL] [Abstract][Full Text] [Related]
9. The Direct Economic Burden of Gout in an Elderly Canadian Population.
Fischer A; Cloutier M; Goodfield J; Borrelli R; Marvin D; Dziarmaga A
J Rheumatol; 2017 Jan; 44(1):95-101. PubMed ID: 27803136
[TBL] [Abstract][Full Text] [Related]
10. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
[TBL] [Abstract][Full Text] [Related]
11. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013.
Soliman AM; Yang H; Du EX; Kelkar SS; Winkel C
Am J Obstet Gynecol; 2015 Aug; 213(2):141-60. PubMed ID: 25771213
[TBL] [Abstract][Full Text] [Related]
12. Cost of illness and determinants of costs among patients with gout.
Spaetgens B; Wijnands JM; van Durme C; van der Linden S; Boonen A
J Rheumatol; 2015 Feb; 42(2):335-44. PubMed ID: 25399391
[TBL] [Abstract][Full Text] [Related]
13. The direct cost of epilepsy in the United States: A systematic review of estimates.
Begley CE; Durgin TL
Epilepsia; 2015 Sep; 56(9):1376-87. PubMed ID: 26216617
[TBL] [Abstract][Full Text] [Related]
14. The direct and indirect costs associated with endometriosis: a systematic literature review.
Soliman AM; Yang H; Du EX; Kelley C; Winkel C
Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
[TBL] [Abstract][Full Text] [Related]
15. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of overactive bladder in the United States: A systematic literature review.
Powell LC; Szabo SM; Walker D; Gooch K
Neurourol Urodyn; 2018 Apr; 37(4):1241-1249. PubMed ID: 29331047
[TBL] [Abstract][Full Text] [Related]
17. Cost of adult chronic rhinosinusitis: A systematic review.
Smith KA; Orlandi RR; Rudmik L
Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115
[TBL] [Abstract][Full Text] [Related]
18. Resource use and economic impact of patients with gout: a multicenter, population-wide study.
Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J
Reumatol Clin; 2013; 9(2):94-100. PubMed ID: 23313534
[TBL] [Abstract][Full Text] [Related]
19. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.
Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T
PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension.
Gu S; Hu H; Dong H
Pharmacoeconomics; 2016 Jun; 34(6):533-50. PubMed ID: 26714685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
